When it comes to peptide therapy for weight loss, the landscape can be confusing. On one side, you have massively popular, FDA-approved medications that have dominated the news cycle. On the other, you have older, niche peptides favored by compounding pharmacies and biohackers.
Two of the most frequently compared compounds are AOD-9604 and Semaglutide. While both are marketed for fat loss, they operate through entirely different biological mechanisms and have vastly different levels of clinical evidence. Here is the definitive comparison of AOD-9604 vs Semaglutide.
Understanding the Mechanisms
How Semaglutide Works
Semaglutide (known by brand names Wegovy and Ozempic) is a GLP-1 (Glucagon-Like Peptide-1) receptor agonist. It mimics a naturally occurring hormone produced in your gut after you eat.
Semaglutide works via three primary mechanisms:
- Appetite Suppression: It crosses the blood-brain barrier and targets the hypothalamus, drastically reducing hunger and cravings.
- Gastric Emptying: It slows down the rate at which food leaves your stomach, keeping you full for much longer.
- Insulin Regulation: It improves insulin sensitivity and helps the pancreas release the appropriate amount of insulin when blood sugar is high.
How AOD-9604 Works
AOD-9604 (Anti-Obesity Drug 9604) is a modified fragment of Human Growth Hormone (specifically, amino acids 176-191).
Researchers discovered that this specific tail-end of the HGH molecule is responsible for growth hormone's fat-burning properties, but it does not affect IGF-1 levels or cause cellular growth. AOD-9604 works by:
Unlike Semaglutide, AOD-9604 has absolutely no effect on appetite or blood sugar.
- Stimulating Lipolysis: It encourages the breakdown and release of stored fat.
- Inhibiting Lipogenesis: It prevents the body from forming new fat cells.
Not sure which weight loss mechanism is right for your biology? Take our free 5-minute quiz to get a personalized recommendation.
The Evidence Gap: Clinical Trials and Efficacy
This is where the comparison becomes stark. The level of clinical evidence supporting these two peptides is not in the same universe.
Semaglutide is backed by the massive STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program. In these double-blind, placebo-controlled trials involving thousands of participants, users lost an average of 15% to 17% of their total body weight over 68 weeks. It is FDA-approved specifically for chronic weight management and is considered the gold standard in obesity medicine.
AOD-9604 has a much rockier clinical history. While early animal models and Phase 2 human trials showed promise for fat oxidation, the drug ultimately failed its Phase 3 clinical trials. The developer, Metabolic Pharmaceuticals, halted development because the peptide failed to show statistically significant weight loss compared to a placebo in a large human population. Today, AOD-9604 is not FDA-approved for weight loss, though it remains legally available through compounding pharmacies and is approved by the TGA in Australia for cosmetic use.
Side Effects and Tolerability
Because they work differently, their side effect profiles are distinct:
Semaglutide Side Effects: Because it alters digestion and appetite, gastrointestinal side effects are very common, especially when starting or increasing the dose. These include:
- Nausea and occasional vomiting
- Constipation or diarrhea
- Acid reflux and bloating
- Fatigue (often due to rapid caloric deficit)
AOD-9604 Side Effects: Because it does not affect the gut or the brain's hunger centers, AOD-9604 is generally very well tolerated. Side effects are rare and usually limited to:
- Mild redness or pain at the injection site
- Occasional headache
Curious if you should prioritize appetite suppression or metabolic fat burning? Take our free 5-minute quiz to find out.
Which Should You Choose?
When to Choose Semaglutide
If your primary goal is significant, measurable weight loss (15+ pounds), Semaglutide is the undisputed winner. If you struggle with portion control, constant food noise, cravings, or insulin resistance, Semaglutide addresses the root cause of the problem by fixing the brain-gut signaling pathway. It is highly effective, but you must be prepared to manage potential GI side effects.
When to Choose AOD-9604
AOD-9604 is best suited for individuals who are already lean, have their diet and exercise perfectly dialed in, and are looking to target stubborn pockets of body fat (often called "cosmetic fat loss"). Because it does not suppress appetite, it is favored by bodybuilders or athletes who need to consume high calories to maintain muscle mass but want to encourage fat oxidation. It is a subtle optimization tool, not a heavy-hitting weight loss drug.
Frequently Asked Questions
Can you stack AOD-9604 and Semaglutide?
Yes, some advanced telehealth clinics prescribe them together. The logic is that Semaglutide handles the caloric deficit by suppressing appetite, while AOD-9604 upregulates the mobilization of stored fat. However, for most people, Semaglutide alone is more than sufficient.
Why is AOD-9604 still popular if it failed clinical trials?
AOD-9604 remains popular in the fitness and biohacking communities because it offers a way to tap into the fat-burning benefits of Human Growth Hormone without the risks of HGH (like insulin resistance or organ growth). It is viewed as a safe, mild metabolic optimizer rather than an obesity cure.
How are they administered?
Both are typically administered via subcutaneous injection (a tiny needle into the belly fat). Semaglutide is injected once per week, owing to its long half-life. AOD-9604 has a very short half-life and must be injected daily, often in a fasted state before cardiovascular exercise, to be effective.